What is the market doing?
What the tape says about CRVS
Corvus Pharmaceuticals, Inc. is +257% over the past year while the S&P 500 is +23%: 234 points ahead of the market.
+257%
1-year return · S&P 500 +23%
- vs 200-day average
- +12%
vs 200-day average · a clear uptrend
- RSI (14)
- 59
RSI (14) · neutral
- Below its 52-week high
- −42%
Below its 52-week high
Details›
- Last close2026-08-26
- $14.74
- 1 monthS&P 500 +3.7%
- +7.7%
- 1 yearS&P 500 +23%
- +257%
- 5 yearsS&P 500 +87%
- +589%
- vs 50-day average$13.42
- +9.8%
- 52-week high
- $25.52
- 52-week low
- $4.31
- Annualised volatility
- 142%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $334K
| Year | Return |
|---|---|
| 2026 (year to date) | +91% |
| 2025 | +44% |
| 2024 | +204% |
| 2023 | +107% |
| 2022 | −65% |
| 2021 | −32% |
| 2020 | −35% |
| 2019 | +48% |
| 2018 | −65% |
| 2017 | −28% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +15% |
| Feb | 10 | 3 of 10 | −6.1% |
| Mar | 10 | 3 of 10 | −2.6% |
| Apr | 10 | 5 of 10 | −5.5% |
| May | 10 | 6 of 10 | +26% |
| Jun | 10 | 3 of 10 | −5.9% |
| Jul | 11 | 6 of 11 | +5.1% |
| Aug | 11 | 8 of 11 | +14% |
| Sep | 10 | 5 of 10 | +11% |
| Oct | 10 | 4 of 10 | +1.8% |
| Nov | 10 | 6 of 10 | +0.43% |
| Dec | 10 | 2 of 10 | −6.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
Ranks #104 of 145 by Smart Score